Detail akcie Mesa Lab online

Business Summary: Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
Financial Summary: BRIEF: For the nine months ended 31 December 2023, Mesa Laboratories Inc revenues decreased 4% to $157.3M. Net income increased 6% to $337K. Revenues reflect Clinical Genomics segment decrease of 15% to $41.5M, Biopharmaceutical Development segment decrease of 18% to $28.5M, United States segment decrease of 11% to $79.2M, China segment decrease of less than 1% to $18.6M.